Basics Oric Pharmaceuticals, Inc. IPO Date: April 24, 2020 Sector: Healthcare Industry: Biotech Market Cap: $1.06B Activated in VL: True Average Daily Range Avg Daily Range: $0.47 | 3.65% Avg Daily Range (30 D): $0.25 | 2.47% Avg Daily Range (90 D): $0.27 | 3.38% Institutional Daily Volume Avg Daily Volume: .37M Avg Daily Volume (30 D): .69M Avg Daily Volume (90 D): .89M Trade Size Avg Trade Size (Sh.): 84 Avg Trade Size (Sh.) (30 D): 64 Avg Trade Size (Sh.) (90 D): 79 Institutional Trades Total Inst.Trades: 797 Avg Inst. Trade: $1.56M Avg Inst. Trade (30 D): $3.24M Avg Inst. Trade (90 D): $2.16M Avg Inst. Trade Volume: .14M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.67M Avg Closing Trade (30 D): $.98M Avg Closing Trade (90 D): $1.19M Avg Closing Volume: 138.6K     News Jun 6, 2025 @ 8:30 PM ORIC Pharmaceuticals Reports Inducement Grants und... Source: Oric Pharmaceuticals, Inc. Feb 7, 2025 @ 9:30 PM ORIC Pharmaceuticals Reports Inducement Grants und... Source: Oric Pharmaceuticals, Inc. Jan 15, 2025 @ 3:10 PM Cutting-Edge Cancer Therapies Lead the Way into a ... Source: Prnewswire Jan 3, 2025 @ 9:30 PM ORIC Pharmaceuticals Reports Inducement Grants ... Source: Oric Pharmaceuticals, Inc. Nov 20, 2024 @ 12:00 PM C4 Therapeutics Appoints Accomplished Oncology Exe... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $-1.89 $-.47 $-.42 Diluted EPS $-1.89 $-.47 $-.42 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -137.25M $ -36.36M $ -30.02M Operating Income / Loss $ -149.67M $ -39.06M $ -32.72M Cost of Revenue $ $ $ Net Cash Flow $ 26.03M $ 26.53M $ -10.07M PE Ratio